Laparoscopic Hysterectomy — How It Works, Benefits & Recovery — Procedure Guide, Recovery & Risks | MyMedicPlus

Laparoscopic hysterectomy is a minimally invasive surgical procedure to remove the uterus using 3–4 small keyhole incisions (5–12 mm ports) under general anaesthesia, guided by a high-definition laparoscope and specialised endoscopic instruments. It represents a major technical advance over the traditional open abdominal hysterectomy (TAH), which requires a 10–15 cm incision and carries significantly longer hospital stay and recovery. Laparoscopic hysterectomy may be classified as total laparoscopic hysterectomy (TLH — cervix removed); laparoscopic-assisted vaginal hysterectomy (LAVH — uterus removed vaginally after laparoscopic mobilisation); or subtotal laparoscopic hysterectomy (SLH — cervix preserved). The ovaries and fallopian tubes may be additionally removed (bilateral salpingo-oophorectomy) depending on the indication — causing immediate surgical menopause if performed before natural menopause. Laparoscopic hysterectomy is performed by subspecialist gynaecological surgeons with advanced laparoscopic training. Robotic-assisted laparoscopic hysterectomy (using da Vinci surgical system) offers 3D visualisation and wristed instruments for complex cases including obesity, previous pelvic surgery, and large uteri. Per RCOG and ACOG guidelines, laparoscopic or vaginal approaches are preferred over abdominal hysterectomy for benign disease.

This treatment represents an important component of modern medical management, supported by clinical evidence from multiple randomised controlled trials and systematic reviews. Treatment protocols are continually refined based on emerging evidence to optimise patient outcomes while minimising treatment burden.

Patient suitability is assessed through a structured multidisciplinary evaluation incorporating clinical history, physical examination findings, and results of relevant investigations. Treatment planning considers the full clinical context including disease characteristics, patient comorbidities, functional status, and individual treatment goals to ensure the most appropriate therapeutic approach is selected for each patient.

Laparoscopic hysterectomy is indicated for benign and malignant conditions requiring uterine removal where minimally invasive access is feasible. Most common benign indications include: symptomatic uterine fibroids (leiomyomata) causing heavy menstrual bleeding, bulk symptoms (pelvic pressure, urinary frequency, constipation), or pain, refractory to medical management and fertility-preserving procedures; endometriosis with severe pelvic pain and involvement of the uterus not amenable to endometriosis excision alone; adenomyosis causing debilitating menorrhagia and dysmenorrhoea, unresponsive to the levonorgestrel-releasing IUS (Mirena), progesterone, or endometrial ablation; uterovaginal prolapse when uterine suspension is inadequate; and heavy menstrual bleeding uncontrolled by medication, endometrial ablation, or LNG-IUS. Gynaecological malignancy indications include: endometrial cancer (stage I–II) — typically performed with pelvic lymphadenectomy; and early cervical cancer (stage IA2–IB1) as modified radical hysterectomy. Patient suitability assessment considers uterine size (laparoscopic approach feasible up to 12–16 weeks' size in most hands), degree of adhesions from previous surgery or endometriosis, BMI, and cardiorespiratory fitness for Trendelenburg positioning under general anaesthesia. Very large uteri may require handport-assisted or robotic surgery.

Under general anaesthesia, the patient is positioned supine in Trendelenburg (tilted 15–30 degrees head-down) with legs in Lloyd-Davies (lithotomy) stirrups to allow simultaneous laparoscopic and vaginal access. A uterine manipulator is inserted through the vagina to mobilise the uterus during surgery. CO2 gas is insufflated into the abdomen through a Veress needle or Hassan trocar at the umbilicus (or Palmer's point in the left upper quadrant if adhesions are suspected centrally) to create a pneumoperitoneum. The laparoscope (10 mm, 30-degree lens) is introduced through the umbilical port. Three additional 5–12 mm working ports are placed in the lower abdomen. The round ligaments are divided bilaterally using an energy device (bipolar/LigaSure or ultrasonic shears). The broad ligament, uterovesical peritoneum, bladder, and ureters are identified and dissected. Uterine arteries are identified, skeletonised, and sealed with energy device or suture ligation at their origin from the internal iliac vessels. The vaginal vault is incised colpotomically with monopolar scissors following the uterine manipulator. The uterus is removed vaginally (intact if size permits) or after morcellation (laparoscopic power morcellation is now restricted due to concerns of disseminating undetected leiomyosarcoma). The vaginal vault is sutured laparoscopically with figure-of-eight absorbable sutures. Total operative time is 1–2.5 hours depending on complexity.

Laparoscopic hysterectomy offers demonstrably superior recovery compared to open abdominal hysterectomy across multiple outcome domains. Hospital stay is reduced from 3–5 days (open) to 1–2 days (laparoscopic). Return to normal activities and work is achieved 2–3 weeks post-laparoscopic versus 6 weeks post-open hysterectomy. Blood loss during laparoscopic surgery is significantly lower (150–300 mL versus 400–600 mL for open), reducing transfusion requirements by 50–60%. Wound infection and abdominal wound complications are virtually eliminated with keyhole incisions. Post-operative pain scores are substantially lower, reducing opioid requirements by 40–50%. Patient satisfaction exceeds 90% in randomised controlled trials comparing laparoscopic to open hysterectomy. Overall complication rates are equivalent between experienced laparoscopic and open surgeons. For medical tourism, laparoscopic hysterectomy in India costs approximately INR 60,000–1,20,000 (USD 720–1,440), compared to USD 15,000–30,000 in the USA or GBP 8,000–18,000 in the UK. The 100% cure rate for benign hysterectomy indications (source organ completely removed) provides definitive resolution of symptoms.

Laparoscopic hysterectomy is associated with a 1–3% major complication rate in experienced hands. Urological injuries — the most feared complication — include bladder injury (0.5–2%) and ureteral injury (0.3–1%); risk is higher in cases with dense endometriotic adhesions, previous pelvic surgery, or large lateral fibroids distorting anatomy. Ureteral injuries may not be recognised intraoperatively and present with flank pain or urinary fistula post-operatively — intraoperative cystoscopy to confirm ureteral jets at procedure end is strongly recommended. Bowel injury occurs in under 0.5% but may be unrecognised, presenting with peritonitis 2–5 days post-operatively. Haemorrhage requiring transfusion occurs in 1–2%. Vaginal cuff dehiscence — separation of the sutured vaginal vault — occurs in 0.3–1% and presents with pelvic pain, discharge, and bowel or small bowel evisceration through the vaginal vault, requiring emergency surgical repair. Port-site hernia occurs in under 1% at 10–12 mm port sites. Conversion to open surgery occurs in approximately 5% due to haemorrhage, dense adhesions, or poor visualisation. If bilateral oophorectomy is performed in a pre-menopausal woman, surgical menopause begins immediately with vasomotor symptoms, urogenital atrophy, and increased cardiovascular risk — hormone replacement therapy (HRT) is recommended for women under 51 years.

Patients are typically discharged 1–2 days after laparoscopic hysterectomy when oral analgesia controls pain, oral intake is tolerated, and voiding is confirmed. A urinary catheter placed at the start of surgery is removed at 24 hours. Oral analgesics (regular paracetamol plus ibuprofen, with short-course tramadol if needed) provide effective post-operative pain control. Early mobilisation — sitting in a chair and walking to the bathroom — begins on the day of surgery to prevent DVT, pulmonary embolism, and ileus. Vaginal rest is mandatory for 6–8 weeks post-operatively: no sexual intercourse, tampons, vaginal douching, or examination to protect the healing vaginal vault. Showering is permitted from 24 hours; deep baths are avoided for 2 weeks. Return to desk work is typically at 2–3 weeks. Physical labour, heavy lifting, and vigorous exercise are delayed until 4–6 weeks. Driving is not permitted for 2 weeks post-surgery (or until emergency stop can be performed comfortably). Light spotting or discharge for 2–4 weeks from the vaginal vault healing is normal — significant bleeding, foul-smelling discharge, or fever require prompt review. Follow-up appointment at 6 weeks assesses vault healing and establishes routine cervical screening intervals (if cervix retained — subtotal hysterectomy). Blood pressure, DVT risk, and wound review are conducted at this visit.